SERPINB4, AS A MARKER FOR AN EARLY EVALUATION OF THE RESPONSE TO ANTI-EGFR THERAPIES BY A NON-INVASIVE METHOD

摘要

The present invention relates to a non-invasive method of assessing, at a very early stage, a response to an anti-EGFR treatment, by measuring the level of expression of SERPINB4 in a sample of hair follicles from the individual who received the anti-EGFR treatment.